Education Australia Approves Lecanemab: New Hope for Early Alzheimer’s Treatment Australia’s Therapeutic Goods Administration (TGA) has approved a new treatment for early Alzheimer’s disease, called lecanemab, marketed under the brand name Leqembi. This decision... Editorial29 September, 2025